Winston Barzell

1.6k total citations
20 papers, 1.2k citations indexed

About

Winston Barzell is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Surgery. According to data from OpenAlex, Winston Barzell has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in Winston Barzell's work include Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Urologic and reproductive health conditions (4 papers). Winston Barzell is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (12 papers), Prostate Cancer Treatment and Research (12 papers) and Urologic and reproductive health conditions (4 papers). Winston Barzell collaborates with scholars based in United States, Canada and United Kingdom. Winston Barzell's co-authors include Willet F. Whitmore, Basil S. Hilaris, Myron R. Melamed, Gary Onik, Michael A. Bean, Harry Grabstald, Jackson E. Fowler, M.A. Batata, Dennis Pessis and Marilyn Campion and has published in prestigious journals such as Cancer, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Winston Barzell

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Winston Barzell United States 13 990 300 291 132 124 20 1.2k
GERALD W. HULL United States 7 1.0k 1.0× 232 0.8× 307 1.1× 103 0.8× 182 1.5× 13 1.2k
Alan Pollack United States 16 972 1.0× 258 0.9× 134 0.5× 178 1.3× 105 0.8× 19 1.3k
Thomas Seay United States 14 862 0.9× 298 1.0× 298 1.0× 44 0.3× 124 1.0× 28 1.1k
Eliahu Gez Israel 12 867 0.9× 215 0.7× 83 0.3× 149 1.1× 164 1.3× 51 1.1k
Emanuele Zaffuto Italy 19 937 0.9× 361 1.2× 254 0.9× 122 0.9× 164 1.3× 70 1.2k
Theo de Reijke Netherlands 15 840 0.8× 127 0.4× 128 0.4× 89 0.7× 101 0.8× 31 1.1k
Carmel Lino Cutajar France 7 1.9k 1.9× 342 1.1× 238 0.8× 139 1.1× 242 2.0× 11 2.1k
Claude Clément Abbou France 16 670 0.7× 237 0.8× 247 0.8× 72 0.5× 130 1.0× 22 854
David W. Keetch United States 19 1.6k 1.6× 374 1.2× 714 2.5× 102 0.8× 156 1.3× 36 1.8k
S. Vincendeau France 20 912 0.9× 303 1.0× 211 0.7× 208 1.6× 144 1.2× 91 1.2k

Countries citing papers authored by Winston Barzell

Since Specialization
Citations

This map shows the geographic impact of Winston Barzell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Winston Barzell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Winston Barzell more than expected).

Fields of papers citing papers by Winston Barzell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Winston Barzell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Winston Barzell. The network helps show where Winston Barzell may publish in the future.

Co-authorship network of co-authors of Winston Barzell

This figure shows the co-authorship network connecting the top 25 collaborators of Winston Barzell. A scholar is included among the top collaborators of Winston Barzell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Winston Barzell. Winston Barzell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Barzell, Winston, Myron R. Melamed, Paul Cathcart, et al.. (2012). Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer. The Journal of Urology. 188(3). 762–768. 71 indexed citations
4.
Onik, Gary & Winston Barzell. (2008). Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy. Urologic Oncology Seminars and Original Investigations. 26(5). 506–510. 112 indexed citations
5.
Bostwick, David G., David J. Waters, Isabelle Meiers, et al.. (2007). Group Consensus Reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology. 70(6). S42–S44. 58 indexed citations
7.
8.
Trachtenberg, John, Marc Gittleman, Christopher P. Steidle, et al.. (2002). A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer. The Journal of Urology. 1670–1674. 96 indexed citations
9.
Trachtenberg, John, Marc Gittleman, Christopher P. Steidle, et al.. (2002). A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer. The Journal of Urology. 167(4). 1670–1674. 101 indexed citations
11.
Roehrborn, Claus G., Glenn M. Preminger, Hassan Razvi, et al.. (1998). Microwave Thermotherapy for Benign Prostatic Hyperplasia With the Dornier Urowave: Results of a Randomized, Double-Blind, Multicenter, Sham-Controlled Trial. The Journal of Urology. 160(1). 273–273. 6 indexed citations
12.
Roehrborn, Claus G., Scott M. Sech, Glenn M. Preminger, et al.. (1997). A randomized, blinded study comparing microwave thermotherapy (dornier urowave(tm)) with a sham procedure in patients with clinical benign prostatic hyperplasia (bph). 80. 3 indexed citations
13.
Vugrin, Davor, Willet F. Whitmore, Esteban Cvitkovic, et al.. (1981). Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor. Cancer. 47(5). 840–844. 34 indexed citations
14.
Fowler, Jackson E., Winston Barzell, Basil S. Hilaris, & Willet F. Whitmore. (1979). Complications of 125 Iodine Implantation and Pelvic Lymphadenectomy in the Treatment of Prostatic Cancer. The Journal of Urology. 121(4). 447–451. 92 indexed citations
15.
Yagoda, Alan, Robin C. Watson, Ronald B. Natale, et al.. (1979). A critical analysis of response criteria in patients with prostatic cancer treated with CIS-diamminedichloride platinum II. Cancer. 44(5). 1553–1562. 78 indexed citations
16.
Yagoda, Alan, Nancy E. Kemeny, Robin C. Watson, et al.. (1978). Diamminedichloride platinum II and cyclophosphamide in the treatment of advanced urothelial cancer. Cancer. 41(6). 2121–2130. 49 indexed citations
17.
Barzell, Winston & Willet F. Whitmore. (1978). Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer. Urological Research. 6(4). 249–251. 3 indexed citations
18.
Barzell, Winston, Michael A. Bean, Basil S. Hilaris, & Willet F. Whitmore. (1977). Prostatic Adenocarcinoma: Relationship of Grade and Local Extent to the Pattern of Metastases. The Journal of Urology. 118(2). 278–282. 161 indexed citations
19.
Hilaris, Basil S., Willet F. Whitmore, M.A. Batata, & Winston Barzell. (1977). Behavioral patterns of prostate adenocarcinoma following an 125I implant and pelvic node dissection. International Journal of Radiation Oncology*Biology*Physics. 2(7-8). 631–637. 93 indexed citations
20.
Gold, Phil, et al.. (1974). Metabolism of rat alpha1-fetoprotein.. PubMed. 34(9). 2296–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026